Top Ligation Devices Companies

Ligation Devices Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.71 Billion in 2025 to USD 2.89 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026–2033).

There are several significant companies in the market for ligation devices, which are moderately consolidated. To increase their market share, the majority of the main players are concentrating on expanding their businesses in emerging nations. Johnson & Johnson, Medtronic plc, Teleflex Incorporated, Olympus Corporation, Applied Medical, ConMed, Cooper Surgical, and B. Braun are a few of the industry participants. 'Medtronic Plc (Ireland)', 'Ethicon US LLC (a subsidiary of Johnson & Johnson) (United States) ', 'Olympus Corporation (Japan) ', 'B. Braun Melsungen AG (Germany) ', 'Teleflex Incorporated (United States) ', 'Applied Medical Resources Corporation (United States) ', 'CooperSurgical Inc. (United States) ', 'Grena Ltd. (United Kingdom) ', 'Boston Scientific Corporation (United States) ', 'Cook Medical LLC (United States) ', 'EndoEvolution LLC (United States) ', 'Genicon Inc. (United States) ', 'Smith & Nephew Plc (United Kingdom) ', 'Stryker Corporation (United States) ', 'The Weck Company (United States) ', 'Unimicro Medical Systems Co. Ltd. (China) ', 'Constance Medical Technologies (France) ', 'IMMI SA (Switzerland) ', 'Fortimedix Surgical (Netherlands)'

Over the projected period, the by-product from the ligation accessories sector is anticipated to hold the biggest market share. The main drivers of this segment's growth are the increase in gastrointestinal and abdominal treatments as well as the move toward minimally invasive surgeries (MIS).

The market will develop in the next few years as a result of rising healthcare spending, which may be utilized to treat numerous cardiovascular diseases and other conditions. Additionally, a rise in the demand for minimally invasive procedures that use ligation devices and related accessories will probably offer the market expansion opportunity in the years to come.

On the basis of region, Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America dominated the market in 2021 as a result of growing expenses and a rise in the number of procedures. With a 40% stake, the U.S. controlled the local market. In addition, rising government investment and the presence of major companies are driving market expansion. During the forecast period, the Asia Pacific region's growth rate will be the fastest. This is because there are more and more gastrointestinal conditions that may be handled with the use of ligation devices and minimally invasive procedures. Numerous endoscopic procedures can make use of these gadgets. Many Asian businesses are concentrating their efforts on creating GI-specific products with an eye toward new markets.